Patient awareness, perceptions, and attitudes towards pharmacists prescribing tobacco cessation medications.
Pharmacist prescribing
Pharmacist prescriptive authority
Scope of practice
Smoking cessation
Tobacco cessation
Journal
Research in social & administrative pharmacy : RSAP
ISSN: 1934-8150
Titre abrégé: Res Social Adm Pharm
Pays: United States
ID NLM: 101231974
Informations de publication
Date de publication:
12 2023
12 2023
Historique:
received:
25
06
2023
revised:
08
08
2023
accepted:
08
08
2023
pmc-release:
01
12
2024
medline:
26
10
2023
pubmed:
1
10
2023
entrez:
30
9
2023
Statut:
ppublish
Résumé
Recent legislative advances now permit pharmacists to prescribe tobacco cessation medications in 17 states. While national initiatives are underway to prepare the pharmacy profession for this expanded role, patient perceptions of this role have not been explored. The objective of this study was to characterize patient perceptions, attitudes, and awareness of pharmacists prescribing for tobacco cessation medications. A cross-sectional survey of English and Spanish-speaking patients was conducted at 12 locations of a federally-qualified health center in Northwest Indiana. Survey measures assessed sociodemographics, tobacco use history and interest in quitting, prior interactions with pharmacists and awareness of pharmacists' ability to prescribe tobacco cessation medications, and perceptions of pharmacists assisting with cessation. The Theory of Planned Behavior (TPB) served as a framework for item development. Multivariable logistic regression was used for modeling. A total of 2082 individuals (1878 English, 204 Spanish) completed the survey (42.4%). Among current users (n = 592; 28.4%), 46.2% had made a quit attempt in the past year, and 41.0% reported having used a tobacco cessation medication in the past. Over half (60.5%) of current users would be comfortable talking with a pharmacist about quitting, 31.9% intended to talk with a pharmacist about quitting, and 31.7% intended to ask a pharmacist to prescribe a medicine to help with quitting. In multivariable modeling, intention to (a) talk with a pharmacist about quitting and (b) ask a pharmacist to prescribe a medication were significantly associated with TPB constructs. Current tobacco users were receptive to pharmacist-facilitated assistance with quitting, including prescribing of tobacco cessation medications. Patients' attitudes, subjective norms, and perceived behavioral control, from the Theory of Planned Behavior, were important predictors of intention to engage with pharmacists for quitting and intention to ask a pharmacist to prescribe a cessation medication.
Sections du résumé
BACKGROUND
Recent legislative advances now permit pharmacists to prescribe tobacco cessation medications in 17 states. While national initiatives are underway to prepare the pharmacy profession for this expanded role, patient perceptions of this role have not been explored.
OBJECTIVE
The objective of this study was to characterize patient perceptions, attitudes, and awareness of pharmacists prescribing for tobacco cessation medications.
METHODS
A cross-sectional survey of English and Spanish-speaking patients was conducted at 12 locations of a federally-qualified health center in Northwest Indiana. Survey measures assessed sociodemographics, tobacco use history and interest in quitting, prior interactions with pharmacists and awareness of pharmacists' ability to prescribe tobacco cessation medications, and perceptions of pharmacists assisting with cessation. The Theory of Planned Behavior (TPB) served as a framework for item development. Multivariable logistic regression was used for modeling.
RESULTS
A total of 2082 individuals (1878 English, 204 Spanish) completed the survey (42.4%). Among current users (n = 592; 28.4%), 46.2% had made a quit attempt in the past year, and 41.0% reported having used a tobacco cessation medication in the past. Over half (60.5%) of current users would be comfortable talking with a pharmacist about quitting, 31.9% intended to talk with a pharmacist about quitting, and 31.7% intended to ask a pharmacist to prescribe a medicine to help with quitting. In multivariable modeling, intention to (a) talk with a pharmacist about quitting and (b) ask a pharmacist to prescribe a medication were significantly associated with TPB constructs. Current tobacco users were receptive to pharmacist-facilitated assistance with quitting, including prescribing of tobacco cessation medications.
CONCLUSIONS
Patients' attitudes, subjective norms, and perceived behavioral control, from the Theory of Planned Behavior, were important predictors of intention to engage with pharmacists for quitting and intention to ask a pharmacist to prescribe a cessation medication.
Identifiants
pubmed: 37777388
pii: S1551-7411(23)00344-3
doi: 10.1016/j.sapharm.2023.08.002
pmc: PMC10625477
mid: NIHMS1929279
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1531-1542Subventions
Organisme : NCI NIH HHS
ID : R25 CA236637
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA117865
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Am Pharm Assoc (2003). 2014 Jan-Feb;54(1):42-4
pubmed: 24407740
J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):387-394
pubmed: 29779983
Int J Clin Pharm. 2021 Dec;43(6):1574-1583
pubmed: 34080087
J Manag Care Spec Pharm. 2014 Jun;20(6):579-87
pubmed: 24856596
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1816-1822.e2
pubmed: 35965233
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1531-1537
pubmed: 35953378
J Contin Educ Health Prof. 2011 Fall;31 Suppl 1:S60-6
pubmed: 22190102
Am J Pharm Educ. 2007 Dec 15;71(6):109
pubmed: 19503693
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):507-14
pubmed: 22825231
J Am Pharm Assoc (2003). 2018 May - Jun;58(3):253-257
pubmed: 29426612
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):397-405
pubmed: 35298455
Drug Alcohol Depend. 2021 Apr 1;221:108615
pubmed: 33652378
Ann Pharmacother. 2012 Sep;46(9):1198-204
pubmed: 22911338
J Am Pharm Assoc (2003). 2003 Sep-Oct;43(5):573-82
pubmed: 14626749
J Cancer Educ. 2003 Fall;18(3):142-9
pubmed: 14512261
Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):477-81
pubmed: 15006926
Patient Educ Couns. 2006 Apr;61(1):152-60
pubmed: 16533683
Prev Med. 2005 Jun;40(6):888-95
pubmed: 15850892
J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):578-82
pubmed: 15496043
J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):568-74
pubmed: 20833613
Am J Med Qual. 2015 Mar-Apr;30(2):135-40
pubmed: 24500644
Res Social Adm Pharm. 2022 Jul;18(7):3158-3163
pubmed: 34544660